Seppo Auriola

Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study

Vanessa D. de Mello, Jussi Paananen, Jaana Lindström et al. · Scientific Reports · 2017 · 377 citations · Full text

Life Sciences, Biochemistry, Diabetology +16

A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen‐containing bisphosphonates

Hannu Mönkkönen, Seppo Auriola, Petri Lehenkari et al. · British Journal of Pharmacology · 2006 · 277 citations · Full text

Medicine, Molecular Biology, Pharmacology +14

Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.

Kirsi Hämäläinen, Kirsi Kananen, Seppo Auriola et al. · PubMed · 1997 · 267 citations

Pharmacy, Biochemistry, Ophthalmology +13

The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: Evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis

Julie C. Frith, Jukka M�nkk�nen, Seppo Auriola et al. · Arthritis & Rheumatism · 2001 · 267 citations

Medicine, Cell Biology, Pharmacology +17

Farnesol and Geranylgeraniol Prevent Activation of Caspases by Aminobisphosphonates: Biochemical Evidence for Two Distinct Pharmacological Classes of Bisphosphonate Drugs

Helena L. Benford, Julie C. Frith, Seppo Auriola et al. · Molecular Pharmacology · 1999 · 257 citations

Life Sciences, Biochemistry, Pharmacology +9